Summary: Oticon Medical’s Sentio System was honored in the Auditory Implants: Bone Conduction category at the fifth annual Hearing Technology Innovator Awards.
Takeaways:
- Award-Winning Technology: Oticon Medical’s Sentio System, the company’s first active transcutaneous bone conduction hearing system, was recognized for its innovation.
- Comprehensive Product Portfolio: The system is part of Oticon’s diverse portfolio, designed to fit various reimbursement systems and clinical settings across different countries.
- Global Impact: Oticon Medical emphasizes that product availability varies by market due to regulatory approvals, underscoring their global reach and adaptability.
Oticon Medical has been recognized for its Sentio System in the fifth annual Hearing Technology Innovator Awards in the category of Auditory Implants: Bone Conduction.
The annual awards program, hosted by Hearing Health & Technology Matters (HHTM), celebrates cutting-edge technological advancements and achievements within the hearing industry. This year’s program saw numerous technologies from companies around the globe, competing across eight distinct categories.
“The Innovator Awards are designed to shine a spotlight on the visionaries and companies turning groundbreaking hearing technology into tangible solutions,” says Robert Traynor, EDD, MBA, FNAP, a member of the 2024 Awards judging panel.
Sentio System is Oticon Medical’s first active transcutaneous bone conduction hearing system. The company now offers a complete product portfolio suitable for the diverse reimbursement systems across countries, adaptable to all professionals and their clinical settings, and most importantly, tailors to the needs of all patients and their different indications.
“We are delighted to have won the Innovator Award for the Sentio System. It is a fantastic achievement to be not simply awarded but recognized for our commitment to innovation in hearing health technology. This validates our team’s hard work and dedication to improving the lives of those with hearing challenges,” says René Govaerts, president & general manager, Oticon Medical.
Not all products are available in all markets. Product availability and indications are subject to regulatory approval and may vary depending on the market, according to Oticon Medical.
